Researchers Are Taking a Second Look at This Promising Alzheimer’s Treatment
After sixteen long years without having any truly viable treatment options for Alzheimer’s, there is some hope on the horizon, in a stunning reversal regarding the previously-rejected antibody therapy, aducanumab. The most recent research shows that large quantities of the medication do, actually, lessen cognitive decline at the beginning stages of Alzheimer’s. As stated by…